M. Collins

527 total citations
10 papers, 421 citations indexed

About

M. Collins is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, M. Collins has authored 10 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in M. Collins's work include Sarcoma Diagnosis and Treatment (3 papers), Vascular Tumors and Angiosarcomas (2 papers) and Cardiac tumors and thrombi (2 papers). M. Collins is often cited by papers focused on Sarcoma Diagnosis and Treatment (3 papers), Vascular Tumors and Angiosarcomas (2 papers) and Cardiac tumors and thrombi (2 papers). M. Collins collaborates with scholars based in United Kingdom and United States. M. Collins's co-authors include M. Leader, J. PATEL, K. Henry, Kristin Henry, J. L. Sever, Clyde J. Dawe, David L. Madden, Paul E. McKeever, Lars M. Wagner and Alexander J. Towbin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

M. Collins

9 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Collins United Kingdom	8	221	167	91	78	58	10	421
J. PATEL United Kingdom	9	244 1.1×	181 1.1×	121 1.3×	83 1.1×	72 1.2×	9	500
Kazuhiro Yakumaru Japan	13	238 1.1×	169 1.0×	64 0.7×	64 0.8×	51 0.9×	36	544
Walter Sch�rch Canada	9	117 0.5×	124 0.7×	75 0.8×	82 1.1×	55 0.9×	9	363
Louise Westberg Strejby Christensen Denmark	10	110 0.5×	118 0.7×	163 1.8×	110 1.4×	25 0.4×	25	521
Mary Ann Perle United States	15	178 0.8×	163 1.0×	298 3.3×	62 0.8×	51 0.9×	42	713
Riikka Huuhtanen Finland	14	312 1.4×	249 1.5×	100 1.1×	84 1.1×	66 1.1×	21	487
Donatella Brancorsini Italy	10	82 0.4×	150 0.9×	129 1.4×	23 0.3×	69 1.2×	27	418
Jeanne-Marie Berner Norway	7	341 1.5×	156 0.9×	198 2.2×	71 0.9×	108 1.9×	8	515
Joslyn Mills United States	9	355 1.6×	251 1.5×	279 3.1×	52 0.7×	66 1.1×	9	631
Sandra Birdsall United Kingdom	12	240 1.1×	119 0.7×	173 1.9×	93 1.2×	168 2.9×	15	488

Countries citing papers authored by M. Collins

Since Specialization

Citations

This map shows the geographic impact of M. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Collins more than expected).

Fields of papers citing papers by M. Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Collins. The network helps show where M. Collins may publish in the future.

Co-authorship network of co-authors of M. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of M. Collins. A scholar is included among the top collaborators of M. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Collins. M. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Dorris, Kathleen, et al.. (2011). INI1 and mib-1 expression in childhood chordomas.. Journal of Clinical Oncology. 29(15_suppl). 9556–9556.

2.

Ma, Zijian, Ashley Hill, M. Collins, et al.. (2000). Alk fusion genes in the pathogenesis of a nonhematopoietic malignancy - inflammatory myofibroblastic tumor (imt). Blood. 96. 1 indexed citations

3.

Leader, M., J. PATEL, M. Collins, & K. Henry. (1989). Myoglobin: an evaluation of its role as a marker of rhabdomyosarcomas. British Journal of Cancer. 59(1). 106–109. 16 indexed citations

4.

Leader, M., J. PATEL, M. Collins, & Kristin Henry. (1987). Anti—α1-Antichymotrypsin Staining of 194 Sarcomas, 38 Carcinomas, and 17 Malignant Melanomas Its Lack of Specificity as a Tumour Marker. The American Journal of Surgical Pathology. 11(2). 133–139. 68 indexed citations

5.

Leader, M., M. Collins, J. PATEL, & K. Henry. (1987). Vimentin: an evaluation of its role as a tumour marker. Histopathology. 11(1). 63–72. 132 indexed citations

6.

Leader, M., M. Collins, J. PATEL, & Kristin Henry. (1987). Desmin: Its value as a marker of muscle derived tumours using a commercial antibody. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 411(4). 345–349. 41 indexed citations

7.

Leader, M., et al.. (1987). Synovial sarcomas true carcinosarcomas?. Cancer. 59(12). 2096–2098. 55 indexed citations

8.

Leader, M., M. Collins, J. PATEL, & K. Henry. (1986). Staining for factor VIII related antigen and Ulex europaeus agglutinin I (UEA‐I) in 230 tumours. An assessment of their specificity for angiosarcoma and Kaposi's sarcoma. Histopathology. 10(11). 1153–1162. 45 indexed citations

9.

Leader, M., M. Collins, J. PATEL, & K. Henry. (1986). Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity.. Journal of Clinical Pathology. 39(11). 1186–1192. 54 indexed citations

10.

Dawe, Clyde J., et al.. (1983). Paralysis in nude mice caused by polyomavirus-induced vertebral tumors.. PubMed. 105. 359–67. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact